There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To compare the 6-month anatomic and best-corrected visual acuity (BCVA) response after
sustained-release dexamethasone (DEX) intravitreal implant between nonvitrectomized
and vitrectomized eyes with persistent diabetic macular edema (DME).